Prolaio is a HealthTech company that focuses on prescriptive analytics.
Prolaio has raised $25.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2023.
Prolaio is headquartered in Scottsdale, United States.
Prolaio is a HealthTech company that focuses on prescriptive analytics.
Prolaio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prolaio — Funding & Investors." VCBacked, July 26, 2023, https://www.vcbacked.co/company/prolaio. Accessed August 8, 2026.
VCBacked. (2023). Prolaio — Funding & Investors. Retrieved August 8, 2026, from https://www.vcbacked.co/company/prolaio
{{cite web |title=Prolaio — Funding & Investors |url=https://www.vcbacked.co/company/prolaio |website=VCBacked |access-date=August 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated